在中风后和多发性硬化症患者中使用肉毒素治疗性治疗:回顾性",现实世界"多中心研究
Calogera Butera1, Marcello Esposito2, Trinchillo Assunta3
1Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
NeuroRehabilitation
|May 28, 2025
概括
毒素-A (BoNT-A) 有效地管理中风和多发性硬化症患者在现实环境中的性. 大多数人对长期的BoNT-A治疗对各种性原因表示满意.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 对于多发性硬化症 (MS) 的肉毒素-A (BoNT-A) 存在有限的现实世界数据,尽管有强有力的证据表明中风后.
- 这项研究解决了临床实践中关于BoNT-A在各种性病因中的缺乏信息的问题.
研究的目的:
- 记录BoNT-A在治疗性的现实应用.
- 专注于治疗中风和多发性硬化症导致的性.
主要方法:
- 采用了一种非干预性,回顾性研究设计.
- 分析了来自149名成年患者的数据,这些患者在2008年至2018年期间在意大利三个中心接受了至少三次BoNT-A注射周期.
- 患者有任何病因的上肢和/或下肢性.
主要成果:
- 分析包括67名中风后,47名多发性硬化和35名其他病因患者.
- 平均治疗持续时间为54.9个月 (中风后) 和41.9个月 (MS).
- 观察到的BoNT-A剂量往往低于批准的剂量,MS和中风后组之间有不同的肌肉治疗模式;然而,患者满意度在病因方面很高.
结论:
- 这项研究提供了对BoNT-A用于性管理的现实世界视角.
- 这些发现支持BoNT-A治疗焦点的有效性和患者满意度,不论其根本原因是什么.
- 这些数据强调了BoNT-A在超出中风指标的长期性护理中的实用性.
关键词:
肉毒毒素A是一种肉毒毒素.多发性硬化症多发性硬化症观察性研究是一种观察性研究.康复康复康复康复康复康复性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性等.一次性中风中风中风中风中风治疗药物 治疗药物更多相关视频
07:20Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
1.4K
05:28Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies
Published on: October 11, 2024
722
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
632
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
632
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
778
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
778
Classification of Skeletal Muscle Relaxants
2.7K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.7K
